JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2008) 198, 157-168    DOI: 10.1677/JOE-07-0428
© 2008 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JOE-07-0428v1
198/1/157    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Stoppa, G. R
Right arrow Articles by Torsoni, M. A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoppa, G. R
Right arrow Articles by Torsoni, M. A

Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling

Graziela R Stoppa, Maristela Cesquini, Erika A Roman, Patrícia O Prada1, Adriana S Torsoni2, Talita Romanatto1, Mario J Saad1, Licio A Velloso1 and Marcio A Torsoni2

Departamento de Bioquímica, IB, Universidade Estadual de Campinas, Campinas, SP, Brazil1 Departamento de Clinica Médica, Universidade Estadual de Campinas, CEP13.083-970 Campinas, SP, Brazil2 Universidade Braz Cubas, Área da Saúde-Campus I, Av. Francisco Rodrigues Filho, 1233, Mogilar, Mogi das Cruzes CEP 08773-380, SP, Brazil

(Correspondence should be addressed to M A Torsoni; Email: torsoni{at}yahoo.com)

We hypothesized that citrate might modulate the AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK)/(ACC) pathway and participate in neuronal feeding control and glucose homeostasis. To address this issue, we injected citrate into the lateral ventricle of rats. Intracerebroventricular (ICV) injection of citrate diminished the phosphorylation of hypothalamic AMPK/ACC, increased the expression of anorexigenic neuropeptide (pro-opiomelanocortin and corticotropin-releasing hormone), elevated the level of malonyl-CoA in the hypothalamus, and reduced food intake. No change was observed in the concentration of blood insulin after the injection of citrate. With a euglycemic–hyperinsulinemic clamp, the glucose infusion rate was higher in the citrate group than in the control group (28.6±0.8 vs 19.3±0.2 mU/kg body weight/min respectively), and so was glucose uptake in skeletal muscle and the epididymal fat pad. Concordantly, insulin receptor (IR), IR substrate type 1 (IRS1), IRS2, and protein kinase B (AKT) phosphorylation in adipose tissue and skeletal muscle was improved by citrate ICV treatment. Moreover, the treatment with citrate for 7 days promoted body weight loss and decreased the adipose tissue. Our results suggest that citrate and glucose may serve as signals of energy and nutrient availability to hypothalamic cells.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Endocrinology.